Should You Buy Veru Inc (VERU) Stock After it Has Gained 6.38% in a Week?

Veru Inc (VERU) stock is higher by 6.38% over the past week and gets a Bullish rating from InvestorsObserver Sentiment Indicator.

Veru Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on VERU!

See Full VERU Report

What is Stock Sentiment?

In investing, sentiment generally means whether or not a given security is in favor with investors. It is typically a pretty short-term metric that relies entirely on technical analysis. That means it doesn’t incorporate anything to do with the health or profitability of the underlying company. Price action is generally the best indicator of sentiment. For a stock to go up, investors must feel good about it. Similarly, a stock that is in a downtrend must be out of favor. InvestorsObserver’s Sentiment Indicator considers price action and recent trends in volume. Increasing volumes often mean that a trend is strengthening, while decreasing volumes can signal that a reversal could come soon. The options market is another place to get signals about sentiment. Since options allow investors to place bets on the price of a stock, we consider the ratio of calls and puts for stocks where options are available.

What's Happening With VERU Stock Today?

Veru Inc (VERU) stock has fallen -6.56% while the S&P 500 has gained 0.44% as of 11:09 AM on Monday, Nov 20. VERU has fallen -$0.07 from the previous closing price of $1.07 on volume of 430,435 shares. Over the past year the S&P 500 is higher by 14.78% while VERU has fallen -81.41%. VERU lost -$1.52 per share in the over the last 12 months.

More About Veru Inc

Veru Inc is a biopharmaceutical company focused on urology and oncology. It develops prescription products for benign prostatic hyperplasia hot flashes associated with cancer treatment, male infertility, and novel chemotherapies for a variety of cancers. The company currently operates in two reporting segments: Sexual health business and Research & development. Some of its products include Zuclomiphene, Veru-111, Veru-100, FC2, and Roman Swipes. The company generates the majority of its revenue from the United States. Click Here to get the full Stock Report for Veru Inc stock.